About this Journal Submit a Manuscript Table of Contents
Clinical and Developmental Immunology
Volume 2013 (2013), Article ID 917068, 15 pages
http://dx.doi.org/10.1155/2013/917068
Research Article

Respiratory-Related Hospitalizations following Prophylaxis in the Canadian Registry for Palivizumab (2005–2012) Compared to Other International Registries

1Department of Pediatrics, McMaster University, Hamilton, ON, Canada L8S 4K1
2McMaster Children’s Hospital, 1280 Main Street West, Room HSC-3A, Hamilton, ON, Canada L8S 4K1
3Department of Pediatrics, University of Calgary, Calgary, AB, Canada T3B 6A8
4Medical Outcomes and Research in Economics (MORE) Research Group, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada M4N 3M5

Received 25 February 2013; Accepted 17 April 2013

Academic Editor: Roberto Burioni

Copyright © 2013 Bosco Paes et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Bosco Paes, Ian Mitchell, Abby Li, Tetsuhiro Harimoto, and Krista L. Lanctôt, “Respiratory-Related Hospitalizations following Prophylaxis in the Canadian Registry for Palivizumab (2005–2012) Compared to Other International Registries,” Clinical and Developmental Immunology, vol. 2013, Article ID 917068, 15 pages, 2013. doi:10.1155/2013/917068